Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis Abstract
Serial isolates of
Mycobacterium tuberculosis were cultured from a patient who failed to respond to standard antituberculous chemotherapy. Isolates were cultured in March 1989, July 1989, December 1989 and May 1990. Each successive isolate was found to be resistant to a wider range of antituberculous drugs than its predecessors. The initial isolate was resistant to isoniazid and rifampin, the second isolate was also resistant to ethambutol, the third was also resistant to pyrazinamide, ansamycin (= rifabutin) and ofloxacin and the last isolate was also resistant to ciprofloxacin and sparfloxacin. All four isolates' bacteriophage typing profiles and DNA restriction fragment patterns determined by Southern blot hybridization using the IS 6110 /IS 986 probes and the new probe pTBN12 were concordant. It was concluded that this patient was persistently infected with a single strain of Mycobacterium tuberculosis which developed resistance to a number of families of drugs but did not show any significant change in typing patterns. The problem of acquired multiple drug resistance, particularly to fluoroquinolones and rifamycins, represents a new challenge in tuberculosis therapy. References
Stybio K, Rouillon A
Estimated global incidence of smear positive pulmonary tuberculosis. Unreliability of officially reported figures on tuberculosis. Bulletin of the International Union against Tuberculosis 1981, 56: 118–125.
Advisory Committee for the Elimination of Tuberculosis
A strategic plan for the elimination of tuberculosis in the United States. Morbidity and Mortality Weekly Report 1989, 38, Supplement 1: 1–25.
Brudney K, Dobkin J
Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of the tuberculosis control programs. American Review of Respiratory Diseases 1991, 144: 745–749.
Monno L, Angarano G, Carbonara S, Coppola S, Costa D, Quarto M, Pastore G
Emergence of drug-resistant
in HIV-infected patients. Lancet 1991, 337: 852.
Perriëns JH, Colebunders RL, Karahunga C, Willame JC, Jeugmans J, Kaboto M, Mukadi Y, Pauwels P, Ryder RW, Prignot J, Piot P
Increased mortality and tuberculosis treatment failure rate among HIV seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with “standard” chemotherapy in Kinshasa, Zaire. American Review of Respiratory Diseases 1991, 144: 750–755.
The U-shaped curve of concern. American Review of Respiratory Diseases 1991, 144: 741–742.
Hermans PWN, van Soolingen D, Dale JW, Schuitma ARJ, McAdam RA, Catty D, van Embden JDA
Insertion element IS
a useful tool for diagnosis and epidemiology of tuberculosis. Journal of Clinical Microbiology 1990, 28: 2051–2058.
Ross BC, Raios K, Jackson K, Dwyer B
Molecular cloning of a highly repeated DNA element from
and its use as an epidemiological tool. Journal of Clinical Microbiology 1992, 30: 942–946.
David HL, Lévy-Frébault V, Thorel MF
Méthode de laboratoire pour mycobactériologie clinique. In: Commission des Laboratoires de Références et d'Expertise de l'Institut Pasteur. Institut Pasteur, Paris, 1989, p. 87.
Rastogi N, Goh KS
In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against
compared with activities of ofloxacin and ciprofloxacin. Antimicrobial Agents and Chemotherapy 1991, 35: 1933–1936.
Rastogi N, Goh KS, David HL
Activity of five fluoro-quinolones against
. Annales de l'Institut Pasteur 1988, 139: 233–237.
Siddiqi SH, Libonati JP, Middlebrook G
Evaluation of a rapid radiometric method for drug-susceptibility testing of
. Journal of Clinical Microbiology 1981, 13: 908–912.
Rado TA, Bates JH, Engel HWB, Mankiewicz E, Murohashi T, Mizugucchi Y, Sula L
World Health Organization studies on bacteriophage typing of mycobacteria. American Review of Respiratory Diseases 1975, 111: 459–468.
Clavel-Sérès S, Clément F
Répartition des lysotypes de
en rélation avec le pays d'origine du malade. Annales de l'Institut Pasteur 1984, 135B: 35–44.
Clavel-Sérès S, Clément F, Jimenez-Mimas C
Répartition des lysotypes de
en France. Revue Française de Maladies Respiratoires 1988, 5: 577–581.
Eisenach KD, Cave DM, Bates JH, Crawford JT
Polymerase chain reaction amplification of a repititive DNA sequence specific for
. Journal of Infectious Diseases 1990, 161: 977–981.
Ross BC, Raios K, Jackson KK, Sievers A, Dwyer B
strains using a non-radioactive Southern blot hybridization method. Journal of Infectious Diseases 1991, 163: 904–907.
McAdam RA, Hermans PMW, van Soolingen D, Zainuddin ZF, Catty D, van Embden JDA, Dale JW
Characterization of a
insertion sequence belonging to the IS
family. Molecular Microbiology 1990, 4: 1607–1613.
Thierry D, Brisson-Noël A, Vincent Lévy-Frébault V, Nguyen S, Guesdon JL, Gicquel B
Characterization of a
insertion sequence, IS
, and its application in diagnosis. Journal of Clinical Microbiology 1990, 28: 2668–2673.
Mazurek GH, Cave MD, Eisenach KD, Wallace RJ, Bates JH, Crawford JT
Chromosomal DNA fingerprint patterns produced with IS
as strainspecific markers for epidemiological study of tuberculosis. Journal of Clinical Microbiology 1991, 29: 2030–2033.
Otal I, Martin C, Vincent Lévy-Frébault V, Thierry D, Gicquel B
Restriction fragment length polymorphism analysis using IS
as an epidemiological marker in tuberculosis. Journal of Clinical Microbiology 1991, 29: 1252–1254.
van Soolingen D, Hermans PWM, de Haas PEW, Soll DR, van Embden JDA
Occurrence and stability of insertion sequences in
complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. Journal of Clinical Microbiology 1991, 29: 2578–2586.
Google Scholar Copyright information
© Friedr, Vieweg & Sohn Verlagsgesellschaft mbH 1992